Dendrimers in anticancer drug delivery: mechanism of interaction of drug and dendrimers

References

• Bagre AP, Jain K, Jain NK. 2013. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment. Int J Pharm. 456:31–40.
   PubMed Web of Science ®Google Scholar
• Cadena LES, Gauthier M. 2010. Phase-segregated dendrigraft copolymer architectures. Polymers. 2:596–622.
   Web of Science ®Google Scholar
• Caminade AM, Turrin CO. 2014. Dendrimers for drug delivery. J Mater Chem B. 2:4055–4066.
   PubMed Web of Science ®Google Scholar
• Daraee H, Eatemadi A, Abbasi E, Fekri Aval S, Kouhi M, Akbarzadeh A. 2014. Application of gold nanoparticles in biomedical and drug delivery. Artif Cells Nanomed Biotechnol. 17:1–13.
   Google Scholar
• Dhankhar R, Vyas SP, Jain AK, Arora S, Rath G, Goyal AK. 2010. Advances in novel drug delivery strategies for breast cancer therapy. Artif Cells Blood Substit Immobil Biotechnol. 38:230–249.
   PubMed Web of Science ®Google Scholar
• Drbohlavova J, Chomoucka J, Adam V, Ryvolova M, Eckschlager T, Hubalek J, Kizek R. 2013. Nanocarriers for anticancer drugs-new trends in nanomedicine. Curr Drug Metab. 14:547–564.
   PubMed Web of Science ®Google Scholar
• Fuertes MA, Alonso C, Pérez JM. 2003. Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance. Chem Rev. 103:645–662.
   PubMed Web of Science ®Google Scholar
• Gillies ER, Fréchet JM. 2005. Dendrimers and dendritic polymers in drug delivery. Drug Discov Today. 10:35–43.
   PubMed Web of Science ®Google Scholar
• Gupta U, Dwivedi SK, Bid HK, Konwar R, Jain NK. 2010. Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cells. Int J Pharm. 393:185–196.
   PubMed Web of Science ®Google Scholar
• He X, Alves CS, Oliveira N, Rodrigues J, Zhu J, Bányai I, Tomás H, Shi X. 2015. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells. Colloids Surf B Biointerfaces. 125:82–89.
   PubMed Web of Science ®Google Scholar
• Howell BA, Fan D. 2009. Poly(amidoamine) dendrimer-supported organoplatinum antitumour agents. Proceedings of the Royal Society of London A: Mathematical, Physical and Engineering Sciences, 2009.
   Google Scholar
• Hu W, Cheng L, Cheng L, Zheng M, Lei Q, Hu Z, et al. 2014. Redox and pH-responsive poly(amidoamine) dendrimer–poly(ethylene glycol) conjugates with disulfide linkages for efficient intracellular drug release. Colloids Surf B Biointerfaces. 123:254–263.
   PubMed Web of Science ®Google Scholar
• Hughes GA. 2005. Nanostructure-mediated drug delivery. Nanomed Nanotechnol Biol Med. 1:22–30.
   PubMed Web of Science ®Google Scholar
• Jain K, Jain NK. 2014a. Dendrimer: A 21st century nanobiopolymer. Pharmabiz; [cited 2015 Oct 7]. Available from: http://www.pharmabiz.com/ArticleDetails.aspx?aid=81282&sid=21
   Google Scholar
• Jain K, Jain NK. 2014b. Surface engineered dendrimers as antiangiogenic agent and carrier for anticancer drug: dual attack on cancer. J Nanosci Nanotechnol. 14:5075–5087.
   PubMed Web of Science ®Google Scholar
• Jain K, Jain NK. 2015. Dendrimers as Nanobiopolymers in Cancer ChemoTherapy: Nanobiomedicine. New Delhi: Studium Press, pp. 65–90.
   Google Scholar
• Jain A, Jain K, Kesharwani P, Jain NK. 2013a. Low density lipoproteins mediated nanoplatforms for cancer targeting. J Nanopart Res. 15:1888.
   Web of Science ®Google Scholar
• Jain A, Jain K, Mehra NK, Jain NK. 2013b. Lipoproteins tethered dendrimeric nanoconstructs for effective targeting to cancer cells. J Nanopart Res. 15:2003
   Web of Science ®Google Scholar
• Jain K, Gupta U, Jain NK. 2014a. Dendronized nanoconjugates of lysine and folate for treatment of cancer. Eur J Pharm Biopharm. 3:500–509.
   Web of Science ®Google Scholar
• Jain K, Kesharwani P, Gupta U, Jain NK. 2012. A review of glycosylated carriers for drug delivery. Biomaterials. 33:4166–4186.
   PubMed Web of Science ®Google Scholar
• Jain K, Kesharwani P, Gupta U, Jain NK. 2010. Dendrimer toxicity: let's meet the challenge. Int J Pharm. 394:122–142.
   PubMed Web of Science ®Google Scholar
• Jain K, Mehra NK, Jain NK. 2014b. Potentials and emerging trends in nanopharmacology. Curr Opin Pharmacol. 15:97–106.
   PubMed Web of Science ®Google Scholar
• Jain K, Verma AK, Mishra PR, Jain NK. 2015a. Characterization and evaluation of amphotericin B loaded MDP conjugated poly (propylene imine) dendrimers. Nanomedicine. 11:705–713.
   PubMed Web of Science ®Google Scholar
• Jain K, Verma AK, Mishra PR, Jain NK. 2015b. Surface engineered dendrimeric nanoconjugates for macrophage targeted delivery of amphotericin B: formulation development, in vitro and in vivo evaluation. Antimicrob Agents Chemother. 59:2479–2487.
   PubMed Web of Science ®Google Scholar
• Kaminskas LM, Mcleod VM, Ascher DB, Ryan GM, Jones S, Haynes JM, et al. 2014. Methotrexate-conjugated PEGylated dendrimers show differential patterns of deposition and activity in tumour-burdened lymph nodes after intravenous and subcutaneous administration in rats. Mol Pharm. 31:343–349.
   Google Scholar
• Kaneshiro TL, Lu ZR. 2009. Targeted intracellular codelivery of chemotherapeutics and nucleic acid with a well-defined dendrimer-based nanoglobular carrier. Biomaterials. 30:5660–5666.
   PubMed Web of Science ®Google Scholar
• Kawaguchi T, Walker KL, Wilkins CL, Moore JS. 1995. Double exponential dendrimer growth. J Am Chem Soc. 117:2159–2165.
   Web of Science ®Google Scholar
• Kesharwani P, Jain K, Jain NK. 2014. Dendrimer as nanocarrier for drug delivery. Prog Polym Sci. 39:268–307.
   Web of Science ®Google Scholar
• Kesharwani P, Tekade RK, Gajbhiye V, Jain K, Jain NK. 2011. Cancer targeting potential of some ligand-anchored poly(propylene imine) dendrimers: a comparison. Nanomedicine. 7:295–304.
   PubMed Web of Science ®Google Scholar
• Klajnert B, Bryszewska M. 2000. Dendrimers: properties and applications. Acta Biochimica Polonica. 48:199–208.
   Web of Science ®Google Scholar
• Kozub P, Simaljakova M. 2011. Systemic therapy of psoriasis: methotrexate. Bratisl Lek Listy. 112:390–394.
   PubMed Web of Science ®Google Scholar
• Lai PS, Lou PJ, Peng CL, Pai CL, Yen WN, Huang MY, Young TH, Shieh MJ. 2007. Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy. J. Control Release. 122:39–46.
   PubMed Web of Science ®Google Scholar
• Li J, Yu F, Chen Y, Oupický D. 2015. Polymeric drugs: advances in the development of pharmacologically active polymers. J Control Release. 219:369–382.
   PubMed Web of Science ®Google Scholar
• Li T, Smet M, Dehaen W, Xu H. 2015. Selenium-platinum coordination dendrimers with controlled anti-cancer activity. ACS Appl Mater Interfaces. DOI: https://doi.org/10.1021/acsami.5b07877.
   Google Scholar
• Liu M., Frechet JM. 1999. Designing dendrimers for drug delivery. Pharm Sci Technol Today. 2:393–401.
   PubMedGoogle Scholar
• Longley DB, Harkin DP, Johnston PG. 2003. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 3:330–338.
   PubMed Web of Science ®Google Scholar
• Madaan K, Kumar S, Poonia N, Lather V, Pandita D. 2014. Dendrimers in drug delivery and targeting: drug-dendrimer interactions and toxicity issues. J Pharm Bioallied Sci. 6:139.
   PubMedGoogle Scholar
• Medina SH, El-Sayed ME. 2009. Dendrimers as carriers for delivery of chemotherapeutic agents. Chem Rev. 109:3141–3157.
   PubMed Web of Science ®Google Scholar
• Mehra NK, Jain K, Jain NK. 2014. Novel Triazine Dendrimer. Encyclopedia of Biomedical Polymers and Polymeric Biomaterials. Boca Raton: Taylor & Francis.
   Google Scholar
• Mehra NK, Jain K, Jain NK. 2015. Pharmaceutical and biomedical applications of surface engineered carbon nanotubes. Drug Discov Today. 20:750–759.
   PubMed Web of Science ®Google Scholar
• Meier W. 2000. Polymer nanocapsules. Chem Soc Rev. 29:295–303.
   Web of Science ®Google Scholar
• Menjoge AR, Kannan RM, Tomalia DA. 2010. Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. Drug Discov Today. 15:171–185.
   PubMed Web of Science ®Google Scholar
• Milhem O, Myles C, Mckeown N, Attwood D, Demanuele A. 2000. Polyamidoamine starburst dendrimers as solubility enhancers. Int J Pharm. 197:239–241.
   PubMed Web of Science ®Google Scholar
• Mishra I. 2011. Dendrimer: a novel drug delivery system. J Drug Deliv Therapeutics. 1:70–74.
   Google Scholar
• Najlah M, D’Emanuele A. 2006. Crossing cellular barriers using dendrimer nanotechnologies. Curr Opin Pharmacol. 6:522–527.
   PubMed Web of Science ®Google Scholar
• Nanjwade BK, Bechra HM, Derkar GK, Manvi F, Nanjwade VK. 2009. Dendrimers: emerging polymers for drug-delivery systems. Eur J Pharm Sci. 38:185–196.
   PubMed Web of Science ®Google Scholar
• Nguyen H, Nguyen NH, Tran NQ, Nguyen CK. 2015. Improved method for preparing cisplatin-dendrimer nanocomplex and its behavior against NCI-H460 lung cancer cell. J Nanosci Nanotechnol. 15:4106–4110.
   PubMed Web of Science ®Google Scholar
• Ooya T, Lee J, Park K. 2003. Effects of ethylene glycol-based graft, star-shaped, and dendritic polymers on solubilization and controlled release of paclitaxel. J Control Release. 93:121–127.
   PubMed Web of Science ®Google Scholar
• Orocio-Rodríguez E, Ferro-Flores G, Santos-Cuevas CL, Ramírez Fde M, Ocampo-García BE, Azorín-Vega E, Sánchez-García FM. 2015. Two novel nanosized radiolabeled analogues of somatostatin for neuroendocrine tumor imaging. J Nanosci Nanotechnol. 15:4159–4169.
   PubMed Web of Science ®Google Scholar
• Patri AK, Kukowskalatallo JF, Baker JR. 2005. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. Adv Drug Deliv Rev. 57:2203–2214.
   PubMed Web of Science ®Google Scholar
• Shi C, He Y, Feng X, Fu D. 2015. ɛ-Polylysine and next-generation dendrigraft poly-l-lysine: chemistry, activity, and applications in biopharmaceuticals. J Biomater Sci Polym Ed. 26:1343–1356.
   PubMed Web of Science ®Google Scholar
• Shukla R, Thomas TP, Desai AM, Kotlyar A, Park SJ, Baker JR. 2008. HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb. Nanotechnology. 19:295102.
   PubMed Web of Science ®Google Scholar
• Svenson S. 2009. Dendrimers as versatile platform in drug delivery applications. Eur J Pharm Biopharm. 71:445–462.
   PubMed Web of Science ®Google Scholar
• Tomalia DA. 2005. Birth of a new macromolecular architecture: dendrimers as quantized building blocks for nanoscale synthetic polymer chemistry. Prog Polym Sci. 30:294–324.
   Web of Science ®Google Scholar
• Turnbull WB, Stoddart JF. 2002. Design and synthesis of glycodendrimers. J. Biotechnol. 90:231–255.
   PubMedGoogle Scholar
• Uram Ł, Szuster M, Filipowicz A, Gargasz K, Wołowiec S, Wałajtys-Rode E. 2015. Different patterns of nuclear and mitochondrial penetration by the G3 PAMAM dendrimer and its biotin-pyridoxal bioconjugate BC-PAMAM in normal and cancer cells in vitro. Int J Nanomed. 10:5647–5661.
   PubMed Web of Science ®Google Scholar
• Wolinsky JB, Grinstaff MW. 2008. Therapeutic and diagnostic applications of dendrimers for cancer treatment. Adv Drug Deliv Rev. 60:1037–1055.
   PubMed Web of Science ®Google Scholar
• Woo S, Lee Y, Sunkara V, Cheedarala RK, Shin HS, Choi HC, Park JW. 2007. “Fingertip”-guided noncovalent functionalization of carbon nanotubes by dendrons. Langmuir. 23:11373–11376.
   PubMed Web of Science ®Google Scholar